Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients

AIM: To study the efficacy and safety of entecavir (ETV) as first-line therapy for hepatitis B virus (HBV) reactivation due to immunosuppression. METHODS: Four patients that were treated with different immunosuppressive regimens for hematological malignancies, who presented with HBV reactivation wer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Brost, Sylvia, Schnitzler, Paul, Stremmel, Wolfgang, Eisenbach, Christoph
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2010
Konular:
Brief Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2988237/
https://ncbi.nlm.nih.gov/pubmed/21086562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v16.i43.5447
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller